The Social and Economic Impact of the New Implantable Cardioverter Defibrillator Technology
作者： S. Saksena
DOI: 10.1007/978-3-642-76575-9_20
关键词: Intensive care medicine 、 Clinical evidence 、 Pharmacotherapy 、 Implantable cardioverter-defibrillator 、 Cardiac mortality 、 Ventricular fibrillation 、 Medicine 、 Arrhythmic death 、 Ventricular tachycardia 、 Epicardial lead
摘要: Rapid technologic advances are accelerating the widespread implementation of implantable cardioverter defibrillator (ICD) therapy for patients with life-threatening ventricular tachycardia or fibrillation. Multiprogrammable ICD pulse generator and nonthoracotomy lead systems can drive process catapulting this therapeutic modality from a last resort investigative option to first-line choice [1–3]. Clinical evidence continues mount in favor superior efficacy devices prevention sudden arrhythmic death as compared empiric directed antiarrhythmic drug [4–6]. Controversy, however, exists on overall impact such total cardiac mortality patients.
springer.com
sci-hub.st 参考文章(16)
Richard N. Fogoros, James J. Elson, Christopher A. Bonnet, Susan B. Fiedler, John A. Burkholder, Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease Journal of the American College of Cardiology. ,vol. 16, pp. 381- 386 ,(1990) , 10.1016/0735-1097(90)90590-L
FRED MORADY, A perspective on the role of catheter ablation in the management of tachyarrhythmias. Pacing and Clinical Electrophysiology. ,vol. 11, pp. 98- 102 ,(1988) , 10.1111/J.1540-8159.1988.TB03933.X
M Kuppermann, B R Luce, B McGovern, P J Podrid, J T Bigger, J N Ruskin, An analysis of the cost effectiveness of the implantable defibrillator. Circulation. ,vol. 81, pp. 91- 100 ,(1990) , 10.1161/01.CIR.81.1.91
Sanjeev Saksena, A. John Camm, Michael Bilitch, John D. Fisher, Seymour Furman, Jerry C. Griffin, Robert G. Hauser, Mark E. Josephson, Helmut Klein, Samuel Levy, Michel Mirowski, Jeremy N. Ruskin, Melvin M. Scheinman, Albert L. Waldo, David E. Ward, Hein J.J. Wellens, Douglas P. Zipes, Clinical investigation of implantable antitachycardia devices: Report of the policy conference of the North American Society of Pacing and Electrophysiology Journal of the American College of Cardiology. ,vol. 10, pp. 225- 229 ,(1987) , 10.1016/S0735-1097(87)80185-7
Seymour Furman, New medical technologies in a cost containment environment: implantable tachyarrhythmia devices. Pacing and Clinical Electrophysiology. ,vol. 10, pp. 1- 1 ,(1987) , 10.1111/J.1540-8159.1987.TB05919.X
Sanjeev Saksena, Initial Clinical Experience With Endocardial Defibrillation Using an Implantable Cardioverter/Defibrillator With a Triple-Electrode System Archives of Internal Medicine. ,vol. 149, pp. 2333- 2339 ,(1989) , 10.1001/ARCHINTE.1989.00390100133028
Anthony D. Mercando, Stanley Epstein, Itzhak Kronzon, Wilbert S. Aronow, Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in elderly patients with heart disease and complex ventricular arrhythmias American Journal of Cardiology. ,vol. 66, pp. 423- 428 ,(1990) , 10.1016/0002-9149(90)90697-Y
Kenneth Jackson, Michael H. Lehmann, Russell T. Steinman, Claudio D. Schuger, The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction American Journal of Cardiology. ,vol. 62, pp. 803- 805 ,(1988) , 10.1016/0002-9149(88)91226-X
Diane Ferguson, Sanjeev Saksena, Estelle Greenberg, William Craelius, Management of recurrent ventricular tachycardia: Economic impact of therapeutic alternatives American Journal of Cardiology. ,vol. 53, pp. 531- 536 ,(1984) , 10.1016/0002-9149(84)90026-2
MITCHELL KRUCOFF, , New Medical Technologies in a Cost Containment Environment: Implantahle Antitachyarrhythmia Devices* Pacing and Clinical Electrophysiology. ,vol. 10, pp. 2- 20 ,(1987) , 10.1111/J.1540-8159.1987.TB05920.X